National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
IN THIS ISSUE
Tailored Cancer Therapy

Molecular Diagnostics

Animation/VideoAnimation/Video

Audio ClipsAudio Clips

Photos/StillsPhotos/Stills

USEFUL CANCER BACKGROUND
Understanding Cancer Series
Show-and-Tell Tutorials

------

NCI Fact Sheets
Briefs on Cancer Topics

------

NewsCenter
Press Releases

------
SEARCH BENCHMARKS
   
  Between these Dates:      
     
     
Search Benchmarks  
    View All Issues  

MEDIA RESOURCES
Noticias En EspaƱol

Understanding Cancer Series

Visuals Online

B-Roll Footage

Radio Broadcasts

Entertainment Resources

Go To Benchmarks Home Page...
Benchmarks
------
Volume 6, Issue 3
------
Audio

TRANSCRIPT: Dr. Taube discusses how to standardize an assay that assigns risk for breast cancer recurrence.


There are many steps along the way, and a lot of things that need to be assessed. There is the actual reproducibility of an assay--if you do it on Monday and you do it again on Tuesday, will you get the same result? There's the standardization, reproducibility and robustness of the assay. But there's also the harder question--does it give you clinically useful information?


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov